Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties

Michiaki Kumagai, Tridib Kumar Sarmat, Horacio Cabral, Sachiko Kaida, Masaki Sekino, Nicholas Herlambang, Kensuke Osada, Mitsunobu Kano, Nobuhiro Nishiyama, Kazunori Kataoka

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

High-density poly(ethylene glycol) (PEG)-coated iron-oxide-gold core-shell nanoparticles (AuIONs) were developed as T2-weighted magnetic resonance imaging (MRI) contrast agents for cancer imaging. The PEG-coated iron-oxide-gold core-shell nanoparticles (PEGAuIONs) were approximately 25 nm in diameter with a narrow distribution. Biodistribution experiments in mice bearing a subcutaneous colon cancer model prepared with C26 murine colon adenocarcinoma cells showed high accumulation of the PEG-AuIONs within the tumor mass and low nonspecific accumulation in the liver and spleen, resulting in high specificity to solid tumors. T2-weighted MR images following intravenous injection of PEG-AuIONs showed selective negative enhancement of tumor tissue in an orthotopic pancreatic cancer model prepared with MiaPaCa-2 human pancreatic adenocarcinoma cells. These results indicate that PEG-AuIONs are a promising MRI contrast agent for diagnosis of malignant tumors, including pancreatic cancer. (Figure Presented)

Original languageEnglish
Pages (from-to)1521-1528
Number of pages8
JournalMacromolecular Rapid Communications
Volume31
Issue number17
DOIs
Publication statusPublished - Sep 1 2010
Externally publishedYes

Fingerprint

Hemodynamics
Magnetic resonance
Iron oxides
Gold
Polyethylene glycols
Tumors
Nanoparticles
Imaging techniques
Contrast Media
Bearings (structural)
Liver
ferric oxide
Tissue
Experiments

Keywords

  • Gold coatings
  • Iron oxide
  • Magnetic resonance imaging
  • Nanoparticles
  • Polyethylene glycol

ASJC Scopus subject areas

  • Organic Chemistry
  • Materials Chemistry
  • Polymers and Plastics

Cite this

Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. / Kumagai, Michiaki; Sarmat, Tridib Kumar; Cabral, Horacio; Kaida, Sachiko; Sekino, Masaki; Herlambang, Nicholas; Osada, Kensuke; Kano, Mitsunobu; Nishiyama, Nobuhiro; Kataoka, Kazunori.

In: Macromolecular Rapid Communications, Vol. 31, No. 17, 01.09.2010, p. 1521-1528.

Research output: Contribution to journalArticle

Kumagai, Michiaki ; Sarmat, Tridib Kumar ; Cabral, Horacio ; Kaida, Sachiko ; Sekino, Masaki ; Herlambang, Nicholas ; Osada, Kensuke ; Kano, Mitsunobu ; Nishiyama, Nobuhiro ; Kataoka, Kazunori. / Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties. In: Macromolecular Rapid Communications. 2010 ; Vol. 31, No. 17. pp. 1521-1528.
@article{17e1ad8a36ab45ada6ec3ede6716c365,
title = "Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties",
abstract = "High-density poly(ethylene glycol) (PEG)-coated iron-oxide-gold core-shell nanoparticles (AuIONs) were developed as T2-weighted magnetic resonance imaging (MRI) contrast agents for cancer imaging. The PEG-coated iron-oxide-gold core-shell nanoparticles (PEGAuIONs) were approximately 25 nm in diameter with a narrow distribution. Biodistribution experiments in mice bearing a subcutaneous colon cancer model prepared with C26 murine colon adenocarcinoma cells showed high accumulation of the PEG-AuIONs within the tumor mass and low nonspecific accumulation in the liver and spleen, resulting in high specificity to solid tumors. T2-weighted MR images following intravenous injection of PEG-AuIONs showed selective negative enhancement of tumor tissue in an orthotopic pancreatic cancer model prepared with MiaPaCa-2 human pancreatic adenocarcinoma cells. These results indicate that PEG-AuIONs are a promising MRI contrast agent for diagnosis of malignant tumors, including pancreatic cancer. (Figure Presented)",
keywords = "Gold coatings, Iron oxide, Magnetic resonance imaging, Nanoparticles, Polyethylene glycol",
author = "Michiaki Kumagai and Sarmat, {Tridib Kumar} and Horacio Cabral and Sachiko Kaida and Masaki Sekino and Nicholas Herlambang and Kensuke Osada and Mitsunobu Kano and Nobuhiro Nishiyama and Kazunori Kataoka",
year = "2010",
month = "9",
day = "1",
doi = "10.1002/marc.201000341",
language = "English",
volume = "31",
pages = "1521--1528",
journal = "Macromolecular Rapid Communications",
issn = "1022-1336",
publisher = "Wiley-VCH Verlag",
number = "17",

}

TY - JOUR

T1 - Enhanced in vivo magnetic resonance imaging of tumors by PEGylated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation properties

AU - Kumagai, Michiaki

AU - Sarmat, Tridib Kumar

AU - Cabral, Horacio

AU - Kaida, Sachiko

AU - Sekino, Masaki

AU - Herlambang, Nicholas

AU - Osada, Kensuke

AU - Kano, Mitsunobu

AU - Nishiyama, Nobuhiro

AU - Kataoka, Kazunori

PY - 2010/9/1

Y1 - 2010/9/1

N2 - High-density poly(ethylene glycol) (PEG)-coated iron-oxide-gold core-shell nanoparticles (AuIONs) were developed as T2-weighted magnetic resonance imaging (MRI) contrast agents for cancer imaging. The PEG-coated iron-oxide-gold core-shell nanoparticles (PEGAuIONs) were approximately 25 nm in diameter with a narrow distribution. Biodistribution experiments in mice bearing a subcutaneous colon cancer model prepared with C26 murine colon adenocarcinoma cells showed high accumulation of the PEG-AuIONs within the tumor mass and low nonspecific accumulation in the liver and spleen, resulting in high specificity to solid tumors. T2-weighted MR images following intravenous injection of PEG-AuIONs showed selective negative enhancement of tumor tissue in an orthotopic pancreatic cancer model prepared with MiaPaCa-2 human pancreatic adenocarcinoma cells. These results indicate that PEG-AuIONs are a promising MRI contrast agent for diagnosis of malignant tumors, including pancreatic cancer. (Figure Presented)

AB - High-density poly(ethylene glycol) (PEG)-coated iron-oxide-gold core-shell nanoparticles (AuIONs) were developed as T2-weighted magnetic resonance imaging (MRI) contrast agents for cancer imaging. The PEG-coated iron-oxide-gold core-shell nanoparticles (PEGAuIONs) were approximately 25 nm in diameter with a narrow distribution. Biodistribution experiments in mice bearing a subcutaneous colon cancer model prepared with C26 murine colon adenocarcinoma cells showed high accumulation of the PEG-AuIONs within the tumor mass and low nonspecific accumulation in the liver and spleen, resulting in high specificity to solid tumors. T2-weighted MR images following intravenous injection of PEG-AuIONs showed selective negative enhancement of tumor tissue in an orthotopic pancreatic cancer model prepared with MiaPaCa-2 human pancreatic adenocarcinoma cells. These results indicate that PEG-AuIONs are a promising MRI contrast agent for diagnosis of malignant tumors, including pancreatic cancer. (Figure Presented)

KW - Gold coatings

KW - Iron oxide

KW - Magnetic resonance imaging

KW - Nanoparticles

KW - Polyethylene glycol

UR - http://www.scopus.com/inward/record.url?scp=77956314660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956314660&partnerID=8YFLogxK

U2 - 10.1002/marc.201000341

DO - 10.1002/marc.201000341

M3 - Article

C2 - 21567561

AN - SCOPUS:77956314660

VL - 31

SP - 1521

EP - 1528

JO - Macromolecular Rapid Communications

JF - Macromolecular Rapid Communications

SN - 1022-1336

IS - 17

ER -